Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3979126 | Bulletin du Cancer | 2010 | 10 Pages |
Abstract
Nasopharyngeal carcinomas (NPC) are predominantly of undifferentiated type (UCNT or undifferentiated carcinoma of nasopharyngeal type), rare (< 1/100000) and sporadic in occidental countries, but endemic in the Mediterranean area of intermediate incidence (2 to 10/100000) and highly frequent (> 10/100000) in South East Asia. NPC staging is based on TNM UICC 2002 that has a prognostic and therapeutic orientation impact. Irradiation of the primitive tumor and its extensions remains the standard loco-regional treatment. The recent introduction of primary and concomitant chemotherapy leads to an improvement in terms of overall and disease-free survival, specially for for high-risk-patients (T3-4 and N2-3 disease). Prognosis remain linked to T, N, histologic type and quality of response to chemotherapy and radiotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hamouda Boussen, Noureddine Bouaouina, Olfa Daldoul, Farouk Benna, Said Gritli, Abderrahman Ladgham,